Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Legend Biotech Corporatio...

    NASDAQ: LEGN · Real-Time Price · USD
    34.71
    -1.13 (-3.15%)
    At close: Jun 17, 2025, 10:20 AM

    Legend Biotech Statistics

    Share Statistics

    Legend Biotech has 92.01M shares outstanding. The number of shares has increased by 0.75% in one year.

    Shares Outstanding

    n/a
    		 92.01M

    Shares Change (YoY)

    n/a
    		 0.75%

    Shares Change (QoQ)

    n/a
    		 0.11%

    Owned by Institutions (%)

    n/a
    		 54.36%

    Shares Floating

    n/a
    		 90.69M

    Failed to Deliver (FTD) Shares

    n/a
    		 799

    FTD / Avg. Volume

    n/a
    		 0.05%

    Short Selling Information

    The latest short interest is 12.84M, so 7% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 12.84M

    Short % of Shares Out

    n/a
    		 7%

    Short % of Float

    n/a
    		 13.36%

    Short Ratio (days to cover)

    n/a
    		 7.91

    Valuation Ratios

    The PE ratio is -16.81 and the forward PE ratio is 61.38. Legend Biotech's PEG ratio is 0.25.

    PE Ratio

    n/a
    		 -16.81

    Forward PE

    n/a
    		 61.38

    PS Ratio

    n/a
    		 4.74

    Forward PS

    n/a
    		 1.1

    PB Ratio

    n/a
    		 2.86

    P/FCF Ratio

    n/a
    		 -18.81

    PEG Ratio

    n/a
    		 0.25
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Legend Biotech.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.34.

    Current Ratio

    n/a
    		 4.62

    Quick Ratio

    n/a
    		 4.54

    Debt / Equity

    n/a
    		 0.34

    Debt / EBITDA

    n/a
    		 -3.1

    Debt / FCF

    n/a
    		 -2.22

    Interest Coverage

    n/a
    		 -14.03

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $241,246.54

    Profits Per Employee

    n/a
    		 $-68,086.92

    Employee Count

    n/a
    		 2,600

    Asset Turnover

    n/a
    		 0.38

    Inventory Turnover

    n/a
    		 9.81

    Taxes

    Income Tax

    n/a
    		 18.89M

    Effective Tax Rate

    n/a
    		 -11.95%

    Stock Price Statistics

    The stock price has increased by -13.73% in the last 52 weeks. The beta is 0.13, so Legend Biotech's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.13

    52-Week Price Change

    n/a
    		 -13.73%

    50-Day Moving Average

    n/a
    		 32.05

    200-Day Moving Average

    n/a
    		 38.37

    Relative Strength Index (RSI)

    n/a
    		 60.62

    Average Volume (20 Days)

    n/a
    		 1,700,050

    Income Statement

    In the last 12 months, Legend Biotech had revenue of 627.24M and earned -177.03M in profits. Earnings per share was -1.94.

    Revenue

    n/a
    		 627.24M

    Gross Profit

    n/a
    		 392.66M

    Operating Income

    n/a
    		 -303.24M

    Net Income

    n/a
    		 -177.03M

    EBITDA

    n/a
    		 -113.16M

    EBIT

    n/a
    		 -136.52M

    Earnings Per Share (EPS)

    n/a
    		 -1.94
    Full Income Statement

    Balance Sheet

    The company has 286.75M in cash and 350.6M in debt, giving a net cash position of -63.85M.

    Cash & Cash Equivalents

    n/a
    		 286.75M

    Total Debt

    n/a
    		 350.6M

    Net Cash

    n/a
    		 -63.85M

    Retained Earnings

    n/a
    		 -1.66B

    Total Assets

    n/a
    		 1.62B

    Working Capital

    n/a
    		 984.42M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -144.03M and capital expenditures -14.11M, giving a free cash flow of -158.14M.

    Operating Cash Flow

    n/a
    		 -144.03M

    Capital Expenditures

    n/a
    		 -14.11M

    Free Cash Flow

    n/a
    		 -158.14M

    FCF Per Share

    n/a
    		 -0.86
    Full Cash Flow Statement

    Margins

    Gross margin is 62.6%, with operating and profit margins of -48.35% and -28.22%.

    Gross Margin

    n/a
    		 62.6%

    Operating Margin

    n/a
    		 -48.35%

    Pretax Margin

    n/a
    		 -25.21%

    Profit Margin

    n/a
    		 -28.22%

    EBITDA Margin

    n/a
    		 -18.04%

    EBIT Margin

    n/a
    		 -48.35%

    FCF Margin

    n/a
    		 -25.21%

    Dividends & Yields

    LEGN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for LEGN is $78, which is 117.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $78

    Price Target Difference

    n/a
    		 117.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 11
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 1.99

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist